Sperling Prostate Center

04/08/2026

Aggressive prostate cancer hiding in the shadows? One study found that 7% of their patients had Grade Group 5 disease despite biopsy showing lower-grade cancer. A researcher suggests a genomic test can reveal dangerous cells missed by biopsy.

Marcio Covas Moschovas: Can a Genomic Test Reveal Aggressive Prostate Cancer that the Biopsy Misses / cancer, Marcio Covas Moschovas, OncoDaily, Oncology,

04/06/2026

Experts say many men delay seeking care, even when symptoms appear, possibly due to broad cultural messaging about male identity.

Researchers and health advocates say many men delay seeking care, even when symptoms appear — a trend the federal government says it hopes to reverse by developing a strategy focused on improving men’s and boys’ health.

04/01/2026

At what age should you start PSA screening? Take the Prostate Cancer Foundation’s personalized quiz to find the answer that’s right for you.

Take the quiz here 👉 https://www.pcf.org/screening-quiz/

03/31/2026

A dietary supplement called modified citrus pectin (made from a fiber found in citrus fruit peels) may help control prostate cancer progression.

PectaSol-C, a dietary supplement formulated from modified citrus pectin, offers the potential to temporarily control biochemical relapse of prostate cancer after primary treatment.

03/30/2026

Did you know? Low-grade prostate cancer can remain indolent for 15-20 years, but high-grade prostate cancer often becomes lethal within a few years, warranting early intervention.

We systematically reviewed the long-term outcomes of untreated prostate cancer across different risk categories to inform treatment decisions and active surveillance protocols. This comprehensive analysis synthesizes long-term progression data across tumor staging and grading systems. We conducted a...

03/29/2026

Poll finds more Americans are making trade-offs with daily living expenses to pay for healthcare.

According to new West Health-Gallup research, millions of Americans report cutting back on expenses and delaying plans because of healthcare costs.

03/28/2026

PSMA imaging could significantly reduce the number of people with suspected prostate cancer who need a biopsy following inconclusive results from an MRI scan.

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found.

03/27/2026

What the heck is focal laser ablation and how does it work? Learn more below 👇

Demystifying what happens during Focal Laser Ablation (FLA), our pioneering MRI-guided treatment that we offer appropriate patients.

03/26/2026

Uh oh. The “forever chemicals” known as PFAS seem to be aging men faster in their 50s and early 60s. These synthetic chemicals are common in non-stick cookware, firefighting foam, food packaging, and waterproof clothing.

Emerging perfluoroalkyl substances (PFAS), such as perfluorononanoic acid (PFNA) and perfluorosulfonic acid (PFSA), are pervasive environmental contaminants ...

03/25/2026

Dr. Dan Sperling was recently videoed by Urology Times, covering topics like mpMRI, in-bore biopsy, and focal treatment. Curious?

👉 Tune in here: https://www.urologytimes.com/view/pearls-perspectives-prostate-mri-and-focal-therapy-with-dan-sperling-md-dabr

03/24/2026

Long term use of non-aspirin over-the-counter pain relievers may actually have a preventive effect against prostate cancer by suppressing systemic inflammation.

Common over-the-counter anti-inflammatory drugs, including aspirin, may help protect against prostate cancer.

03/23/2026

This just in: A new treatment for prostate cancer could halt tumors’ growth by cutting off their blood supply, but it’s not ready for human trials just yet.

A treatment for prostate cancer could halt tumours’ growth by cutting off their blood supply, researchers say.